TG Therapeutics Inc (TGTX)
13.79
-0.20
(-1.43%)
USD |
NASDAQ |
Apr 19, 16:00
13.79
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Revenue (TTM): 233.66M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 233.66M |
| September 30, 2023 | 189.77M |
| June 30, 2023 | 24.05M |
| March 31, 2023 | 8.571M |
| December 31, 2022 | 2.784M |
| September 30, 2022 | 5.025M |
| June 30, 2022 | 6.961M |
| March 31, 2022 | 7.912M |
| December 31, 2021 | 6.689M |
| September 30, 2021 | 4.406M |
| June 30, 2021 | 2.414M |
| March 31, 2021 | 0.907M |
| December 31, 2020 | 0.152M |
| September 30, 2020 | 0.152M |
| June 30, 2020 | 0.152M |
| March 31, 2020 | 0.152M |
| December 31, 2019 | 0.152M |
| September 30, 2019 | 0.152M |
| June 30, 2019 | 0.152M |
| March 31, 2019 | 0.152M |
| December 31, 2018 | 0.152M |
| September 30, 2018 | 0.152M |
| June 30, 2018 | 0.152M |
| March 31, 2018 | 0.152M |
| December 31, 2017 | 0.152M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1517M |
| June 30, 2017 | 0.1518M |
| March 31, 2017 | 0.1519M |
| December 31, 2016 | 0.152M |
| September 30, 2016 | 0.1524M |
| June 30, 2016 | 0.1524M |
| March 31, 2016 | 0.1524M |
| December 31, 2015 | 0.1524M |
| September 30, 2015 | 0.1524M |
| June 30, 2015 | 0.1524M |
| March 31, 2015 | 0.1524M |
| December 31, 2014 | 0.1524M |
| September 30, 2014 | 0.1524M |
| June 30, 2014 | 0.1524M |
| March 31, 2014 | 0.1524M |
| December 31, 2013 | 0.1524M |
| September 30, 2013 | 0.1333M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.152M
Minimum
Jun 2019
233.66M
Maximum
Dec 2023
26.01M
Average
2.784M
Median
Dec 2022
Revenue (TTM) Benchmarks
| Amicus Therapeutics Inc | 399.36M |
| Geron Corp | 0.237M |
| Editas Medicine Inc | 78.12M |
| G1 Therapeutics Inc | 82.51M |
| Mersana Therapeutics Inc | 36.86M |